Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Candidiasis, which includes both superficial infections and invasive disease, is the most common cause of fungal infection worldwide.Candida bloodstream infections (BSI) cause significant mortality and elicit a major threat to intensive care unit (ICU) patients [1].The annual global burden of Candida spp.BSIs is about 400,000 cases, with most cases reported from the developed world.Although Candida albicans remains the most frequently isolated Candida species in the clinical setting, in some countries, a marked shift towards species of Candida that have increased resistance to azoles such as fluconazole (FLU), the standard antifungal drug of choice in many countries, and to the recently introduced antifungals known as echinocandins, is reported.Several species of non-albicans Candida, such as C. tropicalis, C. glabrata, and C. parapsilosis, are well-recognized pathogens in BSIs in different geographic locations.More recently, Candida auris, a multidrug-resistant (MDR) yeast that exhibits resistance to FLU and markedly variable susceptibility to other azoles, amphotericin B (AMB), and echinocandins, has globally emerged as a nosocomial pathogen (Fig 1) [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20].Alarmingly, in a span of only 7 years, this yeast, which is difficult to treat and displays clonal inter-and intra-hospital transmission, has become widespread across several countries, causing a broad range of healthcare-associated invasive infections [4,5,10,12,21,22].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Resistance to all three classes of antifungals is reported most commonly in India in South Asia (3%), whereas this is much less common in other regions of the world.122–124”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Resistance to the echinocandins (up to 7%) and amphotericin B (up to 35%) vary greatly between geographic regions.122–124”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is noted for its potential multidrug antifungal resistance, but the data demonstrate resistance to fluconazole, seen in 70% to 90% of isolates, and they are non-susceptible to quaternary-ammonium disinfectants, allowing this pathogen to persist on healthcare related surfaces and cause outbreaks.122,123”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [123]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the emerging fungal threat C. auris is often MDR.17 , 27 , 36 , 37”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans (2020) · cites this paper as [27]
The cited source says what the claim attributes to it.
In the citing paper
“Most alarmingly, some isolates have been reported to show elevated resistance to all three major antifungal classes, leaving no treatment options for such infections (4).”
From Genetic Analysis of Candida auris Implicates Hsp90 in Morphogenesis and Azole Tolerance and Cdr1 in Azole Resistance (2019) · cites this paper as [4]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Self-citationSatoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381
First hospital outbreak of the globally emerging Candida auris in a European hospital
Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A., Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., et al. (2016) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-016-0132-5 · Cited by 768
Self-citationKathuria, S., Singh, P. K., Sharma, C., Prakash, A., Masih, A., Kumar, A., Meis, J. F., & Chowdhary, A. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00367-15 · Cited by 532
Self-citationFirst Three Reported Cases of Nosocomial Fungemia Caused by Candida auris
Lee, W. G., Shin, J. H., Uh, Y., Kang, M. G., Kim, S. H., Park, K. H., & Jang, H.-C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00319-11 · Cited by 523
Calvo, B., Melo, A. S. A., Perozo-Mena, A., Hernandez, M., Francisco, E. C., Hagen, F., Meis, J. F., & Colombo, A. L. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.07.008 · Cited by 448
Self-citationBiofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris
Sherry, L., Ramage, G., Kean, R., Borman, A., Johnson, E. M., Richardson, M. D., & Rautemaa-Richardson, R. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2302.161320 · Cited by 420
New Clonal Strain of Candida auris, Delhi, India
Chowdhary, A., Sharma, C., Duggal, S., Agarwal, K., Prakash, A., Singh, P. K., Jain, S., Kathuria, S., Randhawa, H. S., Hagen, F., et al. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1910.130393 · Cited by 418
Self-citationLarkin, E., Hager, C., Chandra, J., Mukherjee, P. K., Retuerto, M., Salem, I., Long, L., Isham, N., Kovanda, L., Borroto-Esoda, K., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02396-16 · Cited by 395
Cited by
Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636
Worldwide emergence of resistance to antifungal drugs challenges human health and food security
Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018) · Science · doi:10.1126/science.aap7999 · Cited by 1,555
Tackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
Resistance of Candida to azoles and echinocandins worldwide
Pristov, K. E., & Ghannoum, M. A. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.028 · Cited by 706
Candida auris: a Review of the Literature
Jeffery-Smith, A., Taori, S. K., Schelenz, S., Jeffery, K., Johnson, E. M., Borman, A., Candida auris Incident Management Team, Manuel, R., & Brown, C. S. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-17 · Cited by 595
Chowdhary, A., Prakash, A., Sharma, C., Kordalewska, M., Kumar, A., Sarma, S., Tarai, B., Singh, A., Upadhyaya, G., Upadhyay, S., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx480 · Cited by 577
Self-citationAntifungal drug resistance: evolution, mechanisms and impact
Revie, N. M., Iyer, K. R., Robbins, N., & Cowen, L. E. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.02.005 · Cited by 516
A Candida auris Outbreak and Its Control in an Intensive Care Setting
Eyre, D. W., Sheppard, A. E., Madder, H., Moir, I., Moroney, R., Quan, T. P., Griffiths, D., George, S., Butcher, L., Morgan, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714373 · Cited by 517
On the emergence of Candida auris: climate change, azoles, swamps, and birds
Casadevall, A., Kontoyiannis, D. P., & Robert, V. (2019) · mBio · doi:10.1128/mbio.01397-19 · Cited by 515
Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
Catalano, A., Iacopetta, D., Ceramella, J., Scumaci, D., Giuzio, F., Saturnino, C., Aquaro, S., Rosano, C., & Sinicropi, M. S. (2022) · Molecules · doi:10.3390/molecules27030616 · Cited by 450
Antifungal resistance: current trends and future strategies to combat
Wiederhold, N. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s124918 · Cited by 468
Antifungal Susceptibility Testing: Current Approaches
Berkow, E. L., Lockhart, S. R., & Ostrosky-Zeichner, L. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-19 · Cited by 368
Climate change and the emergence of fungal pathogens
Nnadi, N. E., & Carter, D. A. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009503 · Cited by 373
Potential Fifth Clade of Candida auris, Iran, 2018
Chow, N. A., de Groot, T., Badali, H., Abastabar, M., Chiller, T. M., & Meis, J. F. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2509.190686 · Cited by 356
Self-citationd'Enfert, C., Kaune, A.-K., Alaban, L.-R., Chakraborty, S., Cole, N., Delavy, M., Kosmala, D., Marsaux, B., Fróis-Martins, R., Morelli, M., et al. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa060 · Cited by 347
Ruiz‐Gaitán, A., Moret, A. M., Tasias‐Pitarch, M., Aleixandre‐López, A. I., Martínez‐Morel, H., Calabuig, E., Salavert‐Lletí, M., Ramírez, P., López‐Hontangas, J. L., Hagen, F., et al. (2018) · Mycoses · doi:10.1111/myc.12781 · Cited by 343
Self-citationEpidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris
Cortegiani, A., Misseri, G., Fasciana, T., Giammanco, A., Giarratano, A., & Chowdhary, A. (2018) · Journal of Intensive Care · doi:10.1186/s40560-018-0342-4 · Cited by 329
Self-citationChowdhary, A., Tarai, B., Singh, A., & Sharma, A. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2611.203504 · Cited by 330
Self-citationGlobal epidemiology of emerging Candida auris
Rhodes, J., & Fisher, M. C. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.05.008 · Cited by 315
The rapid emergence of antifungal-resistant human-pathogenic fungi
Lockhart, S. R., Chowdhary, A., & Gold, J. A. W. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00960-9 · Cited by 308
Self-citationOsei Sekyere, J. (2018) · MicrobiologyOpen · doi:10.1002/mbo3.578 · Cited by 300
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Arastehfar, A., Gabaldón, T., Garcia-Rubio, R., Jenks, J. D., Hoenigl, M., Salzer, H. J. F., Ilkit, M., Lass-Flörl, C., & Perlin, D. S. (2020) · Antibiotics · doi:10.3390/antibiotics9120877 · Cited by 292
Chow, N. A., Gade, L., Tsay, S. V., Forsberg, K., Greenko, J. A., Southwick, K. L., Barrett, P. M., Kerins, J. L., Lockhart, S. R., Chiller, T. M., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30597-8 · Cited by 289
Immune defence to invasive fungal infections: A comprehensive review
Pathakumari, B., Liang, G., & Liu, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110550 · Cited by 264
Ahmad, S., & Alfouzan, W. (2021) · Microorganisms · doi:10.3390/microorganisms9040807 · Cited by 269
Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris
Kordalewska, M., Lee, A., Park, S., Berrio, I., Chowdhary, A., Zhao, Y., & Perlin, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00238-18 · Cited by 247
Self-citationEnvironmental Isolation of Candida auris from the Coastal Wetlands of Andaman Islands, India
Arora, P., Singh, P., Wang, Y., Yadav, A., Pawar, K., Singh, A., Padmavati, G., Xu, J., & Chowdhary, A. (2021) · mBio · doi:10.1128/mbio.03181-20 · Cited by 223
Self-citationEscandón, P., Chow, N. A., Caceres, D. H., Gade, L., Berkow, E. L., Armstrong, P., Rivera, S., Misas, E., Duarte, C., Moulton-Meissner, H., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy411 · Cited by 222
Candida auris—the growing menace to global health
Lone, S. A., & Ahmad, A. (2019) · Mycoses · doi:10.1111/myc.12904 · Cited by 208
Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
Faustino, C., & Pinheiro, L. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010029 · Cited by 203
Candida auris and multidrug resistance: Defining the new normal
Lockhart, S. R. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103243 · Cited by 205
Next Generation and Other Sequencing Technologies in Diagnostic Microbiology and Infectious Diseases
Hilt, E. E., & Ferrieri, P. (2022) · Genes · doi:10.3390/genes13091566 · Cited by 199
Invasive candidiasis: current clinical challenges and unmet needs in adult populations
Soriano, A., Honore, P. M., Puerta-Alcalde, P., Garcia-Vidal, C., Pagotto, A., Gonçalves-Bradley, D. C., & Verweij, P. E. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad139 · Cited by 190
The first isolate of Candida auris in China: clinical and biological aspects
Wang, X., Bing, J., Zheng, Q., Zhang, F., Liu, J., Yue, H., Tao, L., Du, H., Wang, Y., Wang, H., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0095-0 · Cited by 191
Ademe, M. (2020) · doi:10.2147/idr.s249864 · Cited by 182
Emerging multidrug-resistant Candida species
Colombo, A. L., Júnior, J. N. D. A., & Guinea, J. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000411 · Cited by 177
Yue, H., Bing, J., Zheng, Q., Zhang, Y., Hu, T., Du, H., Wang, H., & Huang, G. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0187-x · Cited by 176
Candida glabrata: pathogenicity and resistance mechanisms for adaptation and survival
Hassan, Y., Chew, S. Y., & Than, L. T. L. (2021) · Journal of Fungi · doi:10.3390/jof7080667 · Cited by 170
Leach, L., Zhu, Y., & Chaturvedi, S. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01223-17 · Cited by 169
Emerging and reemerging fungal infections
Lockhart, S. R., & Guarner, J. (2019) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2019.04.010 · Cited by 169
Zhu, Y., O’Brien, B., Leach, L., Clarke, A., Bates, M., Adams, E., Ostrowsky, B., Quinn, M., Dufort, E., Southwick, K., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01503-19 · Cited by 162
Aslam, S., Rotstein, C., & Practice, T. A. I. D. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13623 · Cited by 160
Geddes‐McAlister, J., & Shapiro, R. S. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13739 · Cited by 159
The world’s ten most feared fungi
Hyde, K. D., Al‐Hatmi, A. M. S., Andersen, B., Boekhout, T., Buzina, W., Dawson, T. L., Eastwood, D. C., Jones, E. B. G., de Hoog, S., Kang, Y., et al. (2018) · Fungal Diversity · doi:10.1007/s13225-018-0413-9 · Cited by 166
Self-citationAbdolrasouli, A., Armstrong‐James, D., Ryan, L., & Schelenz, S. (2017) · Mycoses · doi:10.1111/myc.12699 · Cited by 150
The antifungal arsenal: alternative drugs and future targets
Wiederhold, N. P. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.09.002 · Cited by 149
Candida auris : An emerging multidrug-resistant pathogen
Sears, D., & Schwartz, B. S. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.08.017 · Cited by 146
Environmental Candida auris and the Global Warming Emergence Hypothesis
Casadevall, A., Kontoyiannis, D. P., & Robert, V. (2021) · mBio · doi:10.1128/mbio.00360-21 · Cited by 145
Bruno, M., Kersten, S., Bain, J. M., Jaeger, M., Rosati, D., Kruppa, M. D., Lowman, D. W., Rice, P. J., Graves, B., Ma, Z., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0780-3 · Cited by 145
Self-citationSynthetic macromolecules as therapeutics that overcome resistance in cancer and microbial infection
Tan, J., Tay, J., Hedrick, J. L., & Yang, Y. Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120078 · Cited by 149
Epidemiology of fungal infections in China
Chen, M., Xu, Y., Hong, N., Yang, Y., Lei, W., Du, L., Zhao, J., Lei, X., Xiong, L., Cai, L., et al. (2018) · Frontiers of Medicine · doi:10.1007/s11684-017-0601-0 · Cited by 137
Fungal persister cells: The basis for recalcitrant infections?
Wuyts, J., Van Dijck, P., & Holtappels, M. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007301 · Cited by 136
Kim, S. H., Iyer, K. R., Pardeshi, L., Muñoz, J. F., Robbins, N., Cuomo, C. A., Wong, K. H., & Cowen, L. E. (2019) · mBio · doi:10.1128/mbio.02529-18 · Cited by 136
Kwon, Y. J., Shin, J. H., Byun, S. A., Choi, M. J., Won, E. J., Lee, D., Lee, S. Y., Chun, S., Lee, J. H., Choi, H., et al. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01624-18 · Cited by 139
Identification of Drug Resistant Candida auris
Kordalewska, M., & Perlin, D. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01918 · Cited by 145
Sabino, R., Veríssimo, C., Pereira, Á. A., & Antunes, F. (2020) · Microorganisms · doi:10.3390/microorganisms8020181 · Cited by 133
Candida auris Infection and Biofilm Formation: Going Beyond the Surface
Horton, M. V., & Nett, J. E. (2020) · Current Clinical Microbiology Reports · doi:10.1007/s40588-020-00143-7 · Cited by 132
Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options
Sardi, J. D. C. O., Silva, D. R., Mendes‐Giannini, M. J. S., & Rosalen, P. L. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.09.014 · Cited by 143
Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation
Santi, C., Scimmi, C., & Sancineto, L. (2021) · Molecules · doi:10.3390/molecules26144230 · Cited by 131
Salmanton-García, J., Cornely, O. A., Stemler, J., Barać, A., Steinmann, J., Siváková, A., Akalin, E. H., Arikan-Akdagli, S., Loughlin, L., Toscano, C., et al. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106229 · Cited by 127
Beardsley, J., Halliday, C. L., Chen, S. C. ‐., & Sorrell, T. C. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0059 · Cited by 146
Szekely, A., Borman, A. M., & Johnson, E. M. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.02055-18 · Cited by 125
Rossow, J., Ostrowsky, B., Adams, E., Greenko, J., McDonald, R., Vallabhaneni, S., Forsberg, K., Perez, S., Lucas, T., Alroy, K. A., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1462 · Cited by 125
Sekyere, J. O., & Asante, J. (2018) · Future Microbiology · doi:10.2217/fmb-2017-0172 · Cited by 128
Fakhim, H., Vaezi, A., Dannaoui, É., Chowdhary, A., Nasiry, D., Faeli, L., Meis, J. F. G. M., & Badali, H. (2018) · Mycoses · doi:10.1111/myc.12754 · Cited by 134
Self-citationBiagi, M. J., Wiederhold, N. P., Gibas, C. F. C., Wickes, B. L., Lozano, V., Bleasdale, S. C., & Danziger, L. H. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz262 · Cited by 122
Hog1 regulates stress tolerance and virulence in the emerging fungal pathogen Candida auris
Day, A. M., McNiff, M. M., da Silva Dantas, A., Gow, N. A. R., & Quinn, J. (2018) · mSphere · doi:10.1128/msphere.00506-18 · Cited by 116
Quindós, G., Marcos‐Arias, C., San-Millán, R., Mateo, E., & Eraso, E. (2018) · International Microbiology · doi:10.1007/s10123-018-0014-1 · Cited by 131
Treatment of Invasive Candidiasis: A Narrative Review
Ben-Ami, R. (2018) · Journal of Fungi · doi:10.3390/jof4030097 · Cited by 111
Khan, Z., Ahmad, S., Al-Sweih, N., Joseph, L., Alfouzan, W., & Asadzadeh, M. (2018) · PLOS ONE · doi:10.1371/journal.pone.0195743 · Cited by 109
Epidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
“122,123 122–124 Because of the potential for person-to-person transmission with C. auris , infection prevention measures are key to preventing nosocomial spread.”
BackgroundReview on Current Status of Echinocandins Use
Mroczyńska, M., & Brillowska‐Dąbrowska, A. (2020) · Antibiotics · doi:10.3390/antibiotics9050227 · Cited by 128
Candida auris otomycosis in Iran and review of recent literature
Abastabar, M., Haghani, I., Ahangarkani, F., Rezai, M. S., Armaki, M. T., Roodgari, S., Kiakojuri, K., Al‐Hatmi, A. M. S., Meis, J. F. G. M., & Badali, H. (2018) · Mycoses · doi:10.1111/myc.12886 · Cited by 120
Self-citationZhang, Y., He, Y., Turrà, D., Zhou, S., Ayhan, D. H., DeIulio, G. A., Guo, L., Broz, K., Wiederhold, N. P., Coleman, J. J., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-0770-2 · Cited by 111
In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris
Fakhim, H., Chowdhary, A., Prakash, A., Vaezi, A., Dannaoui, É., Meis, J. F. G. M., & Badali, H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01056-17 · Cited by 108
Self-citationBhattacharya, S., Holowka, T., Orner, E. P., & Fries, B. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-41513-6 · Cited by 108
Candida auris: a global fungal public health threat
Meis, J. F. G. M., & Chowdhary, A. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30609-1 · Cited by 105
Self-citationKenters, N., Kiernan, M., Chowdhary, A., Denning, D. W., Pemán, J., Saris, K., Schelenz, S., Tartari, E., Widmer, A., Meis, J. F., et al. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.08.013 · Cited by 102
Self-citationNishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102
Self-citationResistance to Antifungal Drugs
Ben‐Ami, R., & Kontoyiannis, D. P. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.003 · Cited by 122
Multi-omics Signature of Candida auris , an Emerging and Multidrug-Resistant Pathogen
Zamith-Miranda, D., Heyman, H. M., Cleare, L. G., Couvillion, S. P., Clair, G. C., Bredeweg, E. L., Gacser, A., Nimrichter, L., Nakayasu, E. S., & Nosanchuk, J. D. (2019) · mSystems · doi:10.1128/msystems.00257-19 · Cited by 99
Candida auris : multi-omics signature of an emerging and multidrug-resistant pathogen
Zamith-Miranda, D., Heyman, H. M., Cleare, L. G., Couvillion, S., Clair, G., Bredeweg, E., Gacser, A., Nimrichter, L., Nakayasu, E. S., & Nosanchuk, J. D. (2019) · doi:10.1101/528232 · Cited by 99
de Jong, A. W., & Hagen, F. (2019) · Mycopathologia · doi:10.1007/s11046-019-00351-w · Cited by 106
Emerging Antifungal Resistance in Fungal Pathogens
Hui, S. T., Gifford, H., & Rhodes, J. L. (2024) · Current Clinical Microbiology Reports · doi:10.1007/s40588-024-00219-8 · Cited by 118
Sariola, S., & Gilbert, S. F. (2020) · Microorganisms · doi:10.3390/microorganisms8050746 · Cited by 111
Candidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches
Tortorano, A. M., Prigitano, A., Morroni, G., Brescini, L., & Barchiesi, F. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s274872 · Cited by 122
Candida aurisin South Africa, 2012–2016
Govender, N. P., Magobo, R. E., Mpembe, R. S., Mhlanga, M., Matlapeng, P., Corcoran, C., Govind, C., Lowman, W., Senekal, M., & Thomas, J. (2018) · Emerging infectious diseases · doi:10.3201/eid2411.180368 · Cited by 108
Candida auris: An emerging drug resistant yeast – A mini-review
Bidaud, A.-L., Chowdhary, A., & Dannaoui, É. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.06.007 · Cited by 103
Self-citationAmbaraghassi, G., Dufresne, P. J., Dufresne, S. F., Vallières, É., Muñoz, J. F., Cuomo, C. A., Berkow, E. L., Lockhart, S. R., & Luong, M. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00884-19 · Cited by 99
Antifungal Resistance in Candida auris: Molecular Determinants
Frías-De-León, M. G., Hernández-Castro, R., Vite-Garín, T., Arenas, R., Bonifaz, A., Castañón-Olivares, L., Acosta-Altamirano, G., & Martínez-Herrera, E. (2020) · Antibiotics · doi:10.3390/antibiotics9090568 · Cited by 93
Gaitán, A. C. R., Martínez, H., Moret, A. M., Calabuig, E., Tasias, M., Alastruey‐Izquierdo, A., Zaragoza, Ó., Mollar, J., Frasquet, J., Salavert, M., et al. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1592675 · Cited by 98
Ghannoum, M. A., Arendrup, M. C., Chaturvedi, V. P., Lockhart, S. R., McCormick, T. S., Chaturvedi, S., Berkow, E. L., Juneja, D., Tarai, B., Azie, N. E., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9090539 · Cited by 96
Araúz, A. B., Cáceres, D. H., Santiago, E., Armstrong, P. A., Arosemena, S. R., Ramos, C., Espinosa-Bode, A., Borace, J., Hayer, L., Cedeño, I., et al. (2017) · Mycoses · doi:10.1111/myc.12709 · Cited by 95
Eldesouky, H. E., Li, X., Abutaleb, N. S., Mohammad, H., & Seleem, M. N. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.08.016 · Cited by 90
Schroeder, M. L., Weber, T., Denker, T., Winterland, S., Wichmann, D., Rohde, H., Ozga, A., Fischer, M., & Kluge, S. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00755-8 · Cited by 99
Welsh, R. M., Sexton, D. J., Forsberg, K., Vallabhaneni, S., & Litvintseva, A. P. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00007-19 · Cited by 97
Wall, G., Chaturvedi, A. K., Wormley, F. L., Wiederhold, N. P., Patterson, H. P., Patterson, T. F., & Lopez-Ribot, J. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01084-18 · Cited by 94
Borman, A. M., Fraser, M., & Johnson, E. M. (2020) · Medical Mycology · doi:10.1093/mmy/myaa049 · Cited by 91
Roudbary, M., Kumar, S., Kumar, A., Černáková, L., Nikoomanesh, F., & Rodrigues, C. F. (2021) · Journal of Fungi · doi:10.3390/jof7090720 · Cited by 95
de Groot, T., Puts, Y., Berrío, I., Chowdhary, A., & Meis, J. F. G. M. (2020) · mBio · doi:10.1128/mbio.02971-19 · Cited by 92
Self-citation
Metadata
- Authors
- Chowdhary, A., Sharma, C., & Meis, J. F.
- Affiliations
- University of Delhi (IN)
- Radboud University Medical Center (NL)
- Corresponding author
- Chowdhary, Anuradha
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-05-18
- Volume
- 13
- Issue
- 5
- Pages
- e1006290
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC5436850
- OpenAlex
- W2615277755
- Semantic Scholar
- d65d18115c1babaac00bdb7ec6bf65d6c629eb32
- Cited by
- 750
- References
- 29
- Citations by year
- 2026: 65 · 2025: 78 · 2024: 73 · 2023: 82 · 2022: 64 · 2021: 95 · 2020: 94 · 2019: 84 · 2018: 83 · 2017: 29
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- University Grants Commission
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida auris, multidrug resistance, nosocomial infections, candidemia, invasive candidiasis, azole resistance, fluconazole resistance, echinocandin resistance, amphotericin B resistance, nosocomial transmission, non-albicans Candida, emerging fungal pathogens
- MeSH terms
- Animals, Candida, Candidiasis, Cross Infection, Humans, Iatrogenic Disease, Drug Resistance, Multiple, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
